BioMarin Pharmaceutical Inc. (BMRN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.039% |
| Hold Price * : | $70.29 |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q3 2024 | |||||
| ≡ | Viking Global Investors | Add 38.08% | 2,689,729 | 0.69 | |
| Q2 2024 | |||||
| ≡ | Viking Global Investors | Add 10.09% | 647,276 | 0.20 | |
| ≡ | Torray Funds | Add 13.61% | 2,019 | 0.03 | |
| Q1 2024 | |||||
| ≡ | Torray Funds | Add 1.15% | 168 | 0.00 | |
| ≡ | Viking Global Investors | Add 31.23% | 1,526,834 | 0.50 | |
| Q4 2023 | |||||
| ≡ | Torray Funds | Add 3.14% | 446 | 0.01 | |
| ≡ | Viking Global Investors | Add 15.99% | 673,998 | 0.24 | |
| ≡ | Daniel Loeb - Third Point | Buy | 385,000 | 0.56 | |
| Q3 2023 | |||||
| ≡ | Dodge & Cox | Add 0.53% | 47,000 | 0.00 | |
| ≡ | Viking Global Investors | Add 1.41% | 58,671 | 0.02 | |
| ≡ | Torray Funds | Add 29.51% | 3,241 | 0.05 | |
| Q2 2023 | |||||
| ≡ | Dodge & Cox | Add 0.36% | 32,200 | 0.00 | |
| ≡ | Torray Funds | Add 0.96% | 104 | 0.00 | |
| ≡ | Viking Global Investors | Add 91.68% | 1,988,168 | 0.71 | |
| Q1 2023 | |||||
| ≡ | Torray Funds | Add 0.40% | 43 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Viking Global Investors | Add 3.42% | 174,456 | 0.09 | |
| Q3 2022 | |||||
| ≡ | Dodge & Cox | Add 0.21% | 18,500 | 0.00 | |
| ≡ | Viking Global Investors | Add 0.92% | 46,571 | 0.02 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Add 34.65% | 1,300,200 | 0.49 | |
| Q1 2022 | |||||
| ≡ | Viking Global Investors | Add 30.75% | 882,446 | 0.28 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Buy | 2,869,947 | 0.74 | |
| Q3 2021 | |||||
| ≡ | Torray Funds | Add 1.26% | 204 | 0.00 | |
| ≡ | Dodge & Cox | Add 6.08% | 515,300 | 0.04 | |
| Q2 2021 | |||||
| ≡ | Torray Funds | Add 0.88% | 142 | 0.00 | |
| ≡ | Dodge & Cox | Add 25.51% | 1,721,565 | 0.16 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 6,480 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Dodge & Cox | Add 22.19% | 1,225,735 | 0.12 | |
| Q4 2020 | |||||
| ≡ | Dodge & Cox | Add 33.33% | 1,380,965 | 0.17 | |
| Q3 2020 | |||||
| ≡ | Torray Funds | Add 26.48% | 14,320 | 0.20 | |
| ≡ | Dodge & Cox | Add 78.10% | 1,816,835 | 0.23 | |
| Q1 2020 | |||||
| ≡ | Torray Funds | Add 7.14% | 4,037 | 0.08 | |
| Q4 2019 | |||||
| ≡ | Dodge & Cox | Buy | 2,956,325 | 0.34 | |
| Q3 2019 | |||||
| ≡ | Torray Funds | Add 0.47% | 954 | 0.01 | |
| ≡ | Viking Global Investors | Add 18.06% | 467,753 | 0.16 | |
| Q2 2012 | |||||
| ≡ | Meridian Contrarian Fund | Add 9.35% | 28,800 | 0.18 | |
| Q1 2010 | |||||
| ≡ | Meridian Contrarian Fund | Add 20.83% | 137,200 | 0.35 | |
| Q3 2009 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 658,700 | 1.33 | |
| Q1 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 104,856 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.